Results 21 to 30 of about 16,538 (257)

Exon2 Mettl3 KO mESCs express altered METTL3 proteins while exon4 Mettl3 KO mESCs do not.

open access: yes, 2022
(A) Exon2 Mettl3 KO mESCs express a novel protein that is immunoreactive to several anti-METTL3 antibodies. We found that exon2 Mettl3 KO mESCs express new proteins that are reactive to an anti-METTL3 pAb.
Hui Xian Poh (13118985)   +3 more
core   +1 more source

7SK methylation by METTL3 promotes transcriptional activity [PDF]

open access: yesScience Advances, 2023
A fundamental feature of cell signaling is the conversion of extracellular signals into adaptive transcriptional responses. The role of RNA modifications in this process is poorly understood. The small nuclear RNA 7SK prevents transcriptional elongation by sequestering the cyclin dependent kinase 9/cyclin T1 (CDK9/CCNT1) positive ...
Marcelo Perez-Pepe   +9 more
openaire   +3 more sources

METTL3-mediated m6A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis

open access: yes, 2023
Doxorubicin (DOX) resistance in breast cancer (BC) poses a huge challenge for the therapeutic effect on BC. Lnc KCNQ1OT1 play crucial roles in chemotherapy resistance.
Zhiyang Zhou (6252770)   +4 more
core   +1 more source

METTL3 regulates heterochromatin in mouse embryonic stem cells [PDF]

open access: yes, 2021
METTL3 (methyltransferase-like 3) mediates the N6-methyladenosine (m6A) methylation of mRNA, which affects the stability of mRNA and its translation into protein1.
Wen, J   +13 more
core   +1 more source

METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10

open access: yesCancer Cell International, 2022
Objective N6-methyladenosine (m6A) RNA methylation is involved in governing the mechanism of tumor progression. We aimed to excavate the biological role and mechanism of the m6A methyltransferase METTL3 in cholangiocarcinoma (CCA).
Jingli Cai   +6 more
doaj   +1 more source

METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma

open access: yesFrontiers in Pharmacology, 2022
Epigenetic regulation plays a critical role in the development, progression, and treatment of tumors. The most common chemical modification of mRNA, called m6A, is essential for controlling mRNA stability, splicing, and translation.
Fangfang Ge   +7 more
doaj   +1 more source

Previously described Mettl3 KO mESC lines express shorter isoforms of Mettl3.

open access: yes, 2022
(A) Mettl3 KO mESCs from two groups have different m6A levels. To reconfirm the m6A levels using quantitative methods, we performed mass spectrometry to estimate the m6A in mRNA.
Hui Xian Poh (13118985)   +3 more
core   +1 more source

The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma

open access: yesJournal of Translational Medicine, 2022
Background As an important N6-methyladenosine (m6A) regulator, abnormal expression of methyltransferase-like protein 3 (METTL3) has been reported in certain human cancers.
Dawei Zhu   +7 more
doaj   +1 more source

METTL3-mediated m6A modification is required for cerebellar development [PDF]

open access: yes, 2018
N6-methyladenosine (m6A) RNA methylation is the most abundant modification on mRNAs and plays important roles in various biological processes. The formation of m6A is catalyzed by a methyltransferase complex including methyltransferase-like 3 (METTL3) as
Wei Li (7081)   +35 more
core   +1 more source

Cry2-mCh-METTL3 interaction with EGFP-METTL3/14.

open access: yes, 2022
(A) Co-immunoprecipitation assay with HEK293T coexpressing Cry2-mCh-METTL3 and EGFP-tagged METTL3 or METTL14. IB, immunoblot; IP, immunoprecipitation; METTL3, methyltransferase-like 3; METTL14, methyltransferase-like 14; WCL, whole cell lysate; WTAP ...
Vivian Hoang (12072856)   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy